Literature DB >> 76798

Long-term transfer-factor treatment for multiple sclerosis.

T Fog, L Pedersen, N E Raun, S Kam-Hansen, E Mellerup, P Platz, L P Ryder, B K Jakobsen, P Grob.   

Abstract

In groups of 16 patients with multiple sclerosis, 13 months' double-blind treatment with transfer factor from random normal donors differed from placebo treatment only in producing a temporary restoration of lymphocyte reactivity to measles virus antigen, and did not arrest the degeneration of nerve tissue.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 76798     DOI: 10.1016/s0140-6736(78)90194-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  3 in total

Review 1.  Multiple sclerosis.

Authors:  C M Poser
Journal:  Med Clin North Am       Date:  1979-07       Impact factor: 5.456

2.  Azathioprine in multiple sclerosis--a 3 year controlled study of its effectiveness.

Authors:  U Patzold; P Pocklington
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

3.  Interferon-alpha and transfer factor in the treatment of multiple sclerosis: a double-blind, placebo-controlled trial. AUSTIMS Research Group.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-05       Impact factor: 10.154

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.